Auewarakul Chirayu Udomsakdi, Promsuwicha Orathai, U-Pratya Yaowaluk, Pattanapanyasat Kovit, Issaragrisil Surapol
Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Asian Pac J Allergy Immunol. 2003 Sep;21(3):153-60.
Little data exists in Thailand and other Southeast Asian countries regarding the biological characteristics of adult acute myeloid leukemia (AML). In this study, we performed a flow cytometric analysis of 267 Thai adult AML cases to delineate the pattern of leukemic cell surface antigens. Forty-eight cases (18%) were identified as acute promyelocytic leukemia (M3) and 219 cases as non-M3. The most frequent subtype of AML in Thailand was M1/M2 and the least frequent was M7. M3 immunophenotypes were characterized by their unique lack of expression of CD34 and HLA-DR as contrast to the high mean expression of 50% and 70%, respectively, in non-M3. Overall, 60% of cases expressed CD34. Aberrant lymphoid antigens were uniquely seen in specific subtypes of Thai AML, including CD19 (33% of non-M3 vs 23% of M3) and CD2 (12% of M3 vs 2% of non-M3). CD56 was frequently expressed in both M3 and non-M3 while CD16 appeared to be associated with M4/M5 (24% of cases) and CD7 with M1/M2 (21% of cases). Eighty-one percent of non-M3 expressed CD38 while only 53% of M3 did. We found that most Thai adult AML patients were on average 15-20 years younger than those of the West or Japan with only 25% of Thai cases over 60 years of age, although the immunophenotypes were not markedly different. Biological studies of acute leukemia in various countries should help to provide epidemiological clues that play a role in the pathogenesis of leukemia in different geographic regions of the world. Our study represents the largest series of AML ever investigated in the Southeast Asian region.
在泰国和其他东南亚国家,关于成人急性髓系白血病(AML)生物学特征的数据很少。在本研究中,我们对267例泰国成人AML病例进行了流式细胞术分析,以描绘白血病细胞表面抗原的模式。48例(18%)被鉴定为急性早幼粒细胞白血病(M3),219例为非M3。泰国AML最常见的亚型是M1/M2,最不常见的是M7。与非M3分别高达50%和70%的平均高表达相比,M3免疫表型的特征是独特地缺乏CD34和HLA-DR表达。总体而言,60%的病例表达CD34。异常淋巴抗原在泰国AML的特定亚型中独特可见,包括CD19(非M3的33% vs M3的23%)和CD2(M3的12% vs非M3的2%)。CD56在M3和非M3中均频繁表达,而CD16似乎与M4/M5相关(24%的病例),CD7与M1/M2相关(21%的病例)。81%的非M3表达CD38,而M3中只有53%表达。我们发现,大多数泰国成人AML患者平均比西方或日本患者年轻15 - 20岁,60岁以上的泰国病例仅占25%,尽管免疫表型没有明显差异。各国对急性白血病的生物学研究应有助于提供流行病学线索,这些线索在世界不同地理区域白血病的发病机制中发挥作用。我们的研究是东南亚地区有史以来对AML进行调查的最大系列研究。